Best Life Sciences Platforms and Tools Companies in Maryland, United States
The 103 best Life Sciences Platforms and Tools companies in Maryland, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: OriGene.
Our analysis of 50 Life Sciences Platforms and Tools companies
$4.8b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Platforms and Tools companies in Maryland
| # | Company | Disclosed funding | Last round | Stage | Employees | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | OriGene Provider and manufacturer of proteins, antibodies, and other molecular tools for research applications | $70M | 132 mo ago | Series D | 141 141 → 130 (-8%) | 1996 | Cart FunctionalityMagentoMySQL+34 | 9 patents Protein microarray platforms for biomarker discovery, disease diagnostics, and gene expression profiling | 1 launch |
| 2 | Seraxis Developer of cell therapy to treat insulin dependent diabetes | $50M | 33 mo ago | Series C | 11 11 → 16 (+45%) | 2013 | — | 68 patents Engineered therapeutic cell platforms, notably pancreatic beta cell therapies for diabetes treatment. | — |
| 3 | WaveGuide Portable micro-nuclear magnetic resonance instruments for on-site testing and analysis | $41M | 13 mo ago | Series B | 6 | 2010 | — | 26 patents Low-field NMR instrumentation with advanced programmable-gain and switched-mode amplifiers | — |
| 4 | RoosterBio Developer of human mesenchymal stem cells and extracellular vesicles | $40M | 27 mo ago | Series B | 69 69 → 58 (-16%) | 2012 | Cart FunctionalityWooCommerceWordPress+27 | 23 patents Optimizing stem cell culture media and extracellular matrices for biofabrication and printing | 3 launchs |
| 5 | Akonni Molecular diagnostics and sample prep solutions for high-quality nucleic acid purification | $40M | 57 mo ago | Series C | 12 12 → 15 (+25%) | 2003 | — | — | — |
| 6 | Mana Therapeutics Developer of therapies for the treatment of cancer | $35M | 54 mo ago | Deadpooled | 9 | 2017 | — | — | — |
| 7 | Gene Logic Integrated genomics company providing comprehensive Genomic Reference Databases and GLP compliant Microarray… | $29M | 347 mo ago | Public | 85 | 1994 | — | — | — |
| 8 | Protein Potential Provides protein services | $23M | 118 mo ago | Funding Raised | — | 2003 | — | 9 patents Oral live-attenuated bacterial vaccine platforms targeting shigellosis, typhoid, and COVID-19 | — |
| 9 | Innovative Biosensors Developer of self-contained biosensor system for rapid diagnostic tests | $20M | 171 mo ago | Series B | 1 | 2003 | — | — | — |
| 10 | Sigmovir Developing the cotton rat as a model for human infectious disease research | $15M | 22 mo ago | Funding Raised | 13 | 2010 | — | — | — |
| 11 | Circulomics Provider of a platform for genome profiling and biomarker analysis | $15M | 69 mo ago | Acquired | 10 | 2009 | — | 16 patents Silica‑based magnetic nanomaterials for high‑molecular‑weight DNA extraction and size selection | — |
| 12 | Emit Imaging Developer of 3D fluorescence high-resolution molecular imaging for researchers | $11M | 21 mo ago | Series A | 8 | 2018 | — | — | — |
| 13 | Benevir Innovative medicine, therapies, and medical technology for global healthcare solutions | $11M | 103 mo ago | Acquired | 10 | 2011 | — | — | — |
| 14 | Vigene Biosciences Developer of life science research reagents for drug discovery and functional genomics | $10M | 74 mo ago | Acquired | 45 | 2012 | — | — | — |
| 15 | Xceleron Analytical CRO with expertise in AMS (Accelerator Mass Spectrometry) technology | $10M | 172 mo ago | Acquired | 25 | 1997 | — | — | — |
| 16 | IBT Bio Services CRO providing preclinical and clinical research services, reagents, and animal models | $8M | 156 mo ago | Funding Raised | 21 | 2005 | — | — | — |
| 17 | CosmosID Developer of next-generation sequencing (NGS) technologies for the detection of microorganisms | $7M | 84 mo ago | Series B | 7 | 2008 | WordPressMySQLPHP+23 | 19 patents Microbial DNA sequencing for identification, quantification, and trait analysis of microorganisms. | — |
| 18 | Kemp Proteins Developer of protein expression systems | $5M | 48 mo ago | Acquired | 28 | 2008 | — | — | — |
| 19 | Hememics Biotechnologies Developer of techology platform for biopreservation | $5M | 36 mo ago | Seed | 13 | 2009 | — | 36 patents Rapid multiplex point‑of‑care biosensors employing carbon‑nanotube nanomaterials | — |
| 20 | Microprobes for Life Science Provider of microelectrodes and microelectrode arrays for electrophysiology studies | $4M | 81 mo ago | Funding Raised | — | 1983 | JoomlaPHPBootstrap+11 | — | — |
| 21 | MultiplexDX Provider of solutions for the molecular diagnostics market | $3M | 41 mo ago | Seed | 35 | 2015 | Webflowcore-jsjQuery+11 | — | — |
| 22 | C-Perl Custom protein expression and recovery services | $3M | 191 mo ago | Funding Raised | 11 | 2000 | — | — | — |
| 23 | Papgene Diagnostics company focused on commercializing molecular tests for early detection of cancer | $3M | 124 mo ago | Deadpooled | — | 2014 | — | — | — |
| 24 | Fina Biosolutions Conjugate vaccine solutions, bioconjugation services, and functionalized dextrans for emerging markets | $3M | 20 mo ago | Seed | 8 | 2006 | — | 91 patents Efficient cytoplasmic production of soluble recombinant therapeutic proteins | — |
| 25 | Potomac Affinity Proteins Engineering proteases for life science research, diagnostics, biodefense, and therapeutics | $3M | 171 mo ago | Funding Raised | 5 | 2005 | — | 6 patents Directed evolution platforms for engineering enzymes with tailored catalytic activities | — |
| 26 | BioFortis Global clinical trial laboratory services accelerating drug discovery and development | $3M | 200 mo ago | Funding Raised | 43 | 2002 | — | 5 patents Low-code UI generation and visual database query builder tools for software development. | — |
| 27 | Tethys Research Enzyme and metabolite discovery through unique methodologies for chemical product innovation | $3M | 58 mo ago | Funding Raised | — | 2000 | — | — | — |
| 28 | Primetime Life Sciences Developer of translational medicine | $3M | 81 mo ago | Funding Raised | — | 2011 | — | — | — |
| 29 | Plasmonix Exploring Scrum development, agile methodologies, and project management approaches | $3M | 131 mo ago | Seed | — | 2009 | — | 3 patents Plasmonic-enhanced fluorescence microarray substrates for increased signal detection | — |
| 30 | DeepBiome Therapeutics Developer of novel therapeutics addressing unmet needs in immune-related diseases | $3M | 80 mo ago | Deadpooled | 7 | 2017 | — | — | — |
| 31 | Zeteo Tech Manufacturer of biological mass spectrometers | $2M | 9 mo ago | Seed | 19 19 → 20 (+5%) | 2013 | — | — | — |
| 32 | Next Heathcare Stem cells banking for use in future treatment and therapies. | $2M | 76 mo ago | Deadpooled | 7 | 2009 | — | — | — |
| 33 | MassTech AP MALDI mass spectrometry solutions for research and analytical applications | $1M | 186 mo ago | Funding Raised | 15 | 2001 | — | — | — |
| 34 | Diagnostic Biochips Developer of diagnostic biosensors for continuous monitoring | $1M | 63 mo ago | Series A | 7 | 2012 | — | — | — |
| 35 | Otomagnetics Developing non-invasive magnetic drug delivery technology for targeted therapies | $1M | 99 mo ago | Seed | 10 | 2012 | — | 50 patents Targeted magnetic drug delivery and magnetic therapy devices for ear and skin | — |
| 36 | Spectral Dimensions Laboratory instruments | $1M | 267 mo ago | Acquired | — | 1971 | — | 5 patents Spectroscopic analytical methods for pharmaceutical formulation evaluation and imaging calibration | — |
| 37 | Intelligent Substrates Provider of microenvironments for in vitro cell culture research, tissue engineering, and drug discovery | $980K | 200 mo ago | Deadpooled | — | 2007 | — | — | — |
| 38 | Donor Egg Bank USA Frozen donor egg bank offering diverse donors and financial security | $778K | 142 mo ago | Acquired | 31 | 2011 | WagtailPythonDjango+28 | — | — |
| 39 | xMD Developer of laboratory instruments and consumables for life science research | $775K | 57 mo ago | Seed | 2 | 2015 | — | 8 patents Microfluidic devices for targeted extraction of biomolecules from tissue samples | — |
| 40 | AthenaES Biotechnology company providing protein production, purification tools, and cell culture solutions | $540K | 44 mo ago | Funding Raised | — | 1994 | — | — | — |
| 41 | CC Biotech Develops chromatographic rotors | $467K | 125 mo ago | Funding Raised | 1 | 2006 | — | 109 patents Closed-system cryopreservation devices and microbial silage production technologies | — |
| 42 | NexGen Forensic Sciences Developer of a DNA analysis tools for precision medicine development | $450K | 38 mo ago | Seed | — | — | — | — | — |
| 43 | Brimrose Corporation Acousto-optic devices, spectrometers, and hyperspectral imagers innovator and manufacturer | $344K | 16 mo ago | Funding Raised | 25 | 1980 | Cart FunctionalitySquarespace CommerceSquarespace+17 | 2 patents Automated spatial sensing and image analysis for unattended monitoring systems. | 1 job opening |
| 44 | Gaskiya Developer of protein based diagnosis test for aquatic disease | $325K | 68 mo ago | Deadpooled | 4 | 2016 | — | — | — |
| 45 | Nanocrine Provider of a cell analysis and drug design tool for researchers | $300K | 36 mo ago | Seed | 4 | 2018 | — | — | — |
| 46 | Phycin Developer of an algae-based platform for growth factor production | $200K | 24 mo ago | Funding Raised | — | 2013 | — | — | — |
| 47 | Cellomics Technology Provider of products and services to genetically engineer mammalian somatic and stem cells | $150K | 158 mo ago | Seed | 4 | 2006 | Cart FunctionalityBootstrapMicrosoft ASP.NET+7 | 116 patents Patents concentrated in computing, sensing & instrumentation | — |
| 48 | Euveda Biosciences Developing platform microfluidic technologies that enable drug screening on primary cells | $150K | 175 mo ago | Deadpooled | — | 2011 | — | — | — |
| 49 | EdgeBio Manufacturer and distributor for DNA sequencing and purification | $109K | 191 mo ago | Acquired | 11 | 1989 | UbuntuHeadless UITailwind CSS+15 | — | — |
Top 12 Life Sciences Platforms and Tools companies in Maryland
#1
Series B · Cambridge, Maryland · founded 2010 · 6 employees$41.4Mraised▾
Portable micro-nuclear magnetic resonance instruments for on-site testing and analysis. This innovative technology offers rapid detection and quantification of substances, enabling critical medical, material, and diagnostic tests in various locations. The battery-powered, portable μNMR instrument facilitates quick and easy testing of diverse materials, including motor oil, olive oil, pharmaceuticals, and pathogens, without requiring specialized training. It caters to industries needing authenticity verification, purity measurement, wear and tear analysis, and pathogen detection. The technology can be tailored for specific organizational needs, offering solutions for oncology, pathogen detection, purity measurement, authenticity confirmation, and wear and tear assessment. This revolutionary technology provides on-site analysis, delivering faster results and cost savings.
- May 2025Conventional Debt$3M
- May 2022Series B$8.3M
- May 2019Series A$2.6M
- Nov 2018Series A$3.4M
#2
Seed · Sykesville, Maryland · founded 2013 · 19 employees$2Mraised▾
Zeteo Tech is a manufacturer of biological mass spectrometers. They have developed their own proprietary instrument, digitalMALDI, which identifies airborne microbes, proteins, lipids, and can be used to screen for infectious disease and other bio-threats.
- Aug 2025Grant (prize money)$1.9M
- Aug 2025Grant (prize money)$271.5K
- Apr 2025Grant (prize money)$174.7K
- Aug 2021Grant (prize money)$256K
#3
Funding Raised · Rockville, Maryland · founded 2010 · 13 employees$14.9Mraised▾
Sigmovir Biosystems is a Maryland, US-based biotechnology company that is developing a cotton rat model (genus Sigmodon) as a model for human infectious disease research. The premise is based on studies that have shown species of the cotton rat to be permissive for a wide variety of human viral, bacterial and parasitic pathogens, and to be a more reliable model for these infections than currently used murine models. The model has already been used for multiple drug development and academic programs and is currently considered the model of choice for Respiratory Syncytial Virus infections. Data generated in this animal model has been solely responsible for the FDA approval of clinical trials for Synagis (MedImmune). The company currently offers its model for biological and pharmaceutical research into RSV, hMPV, Influenza, parainfluenza, human adenovirus, measles and HSV infections, and for broader immunology and infectious disease biology research. Specific services include quantitative virology, histopathology, serology/immunology, molecular diagnostics, molecular analysis of inflammatory and immune responses, mucosal immune response evaluation, in vitro screening, development of
- Aug 2024Grant (prize money)$75.5K
- Aug 2023Grant (prize money)$1.1M
- May 2020Grant (prize money)$3.4M
- Feb 2014Grant (prize money)$2.1M
#4
Series A · Baltimore, Maryland · founded 2018 · 8 employees$11.2Mraised▾
Developer of 3D fluorescence high-resolution molecular imaging for researchers. The company has developed a "Xerra" 3d fluorescence imaging system based on Cryo-Fluorescence Tomography (CFT), which is an ex vivo molecular imaging technique that allows high-resolution visualization of cell clusters, isolated organs, and whole animals.
- Sep 2024Series A$7.1M
- Apr 2023Series A$5.9M
#5
Series B · Frederick, Maryland · founded 2012 · 69 employees$40.2Mraised▾
Developer of human mesenchymal stem cells and extracellular vesicles. The company specializes in human bone marrow-derived and adipose-derived MSCs and associated, highly-engineered media formulations for the expansion of these cells.
- Mar 2024Conventional Debt—
- Mar 2024Series B$12M
- Sep 2019Series B$21.5M
- Oct 2017Grant (prize money)—
#6
Seed · Rockville, Maryland · founded 2006 · 8 employees$3Mraised▾
Conjugate vaccine solutions, bioconjugation services, and functionalized dextrans for emerging markets. The company provides bioconjugation services and products, assisting vaccine manufacturers in creating affordable conjugate vaccines. Core expertise lies in conjugation chemistry, bioconjugation, and conjugate vaccines. They offer a range of services including conjugation, protein services, and analytical services like multi-angle light scattering and immunoassay design. Products include carrier proteins like CRM197 and functionalized dextrans, including amino, fluorescent, and custom dextrans. They focus on making vaccine technology accessible, particularly in emerging markets, and offer consulting services to the Biotech and Vaccine industry. They also provide specialty immunoreagents and resources to support vaccine development and production.
- Oct 2024Seed$3M
- Jan 2024Grant (prize money)$300K
- Jan 2024Grant (prize money)$297.8K
- Apr 2020Grant (prize money)$289.1K
#7
Series C · Germantown, Maryland · founded 2013 · 11 employees$50Mraised▾
Seraxis is a biotech company developing a cell therapy for the treatment of diabetes. The company's proprietary approach includes harvesting donor pancreatic islet cells and reprogram them into a stable stem-cell state for long-term cry-preservation. At the time of therapy, the cells are redifferentiated to islet cells, packaged in the company's proprietary membrane-based microcapsule packaging system, and injected into the patient's body. The membrane ensures a low risk of immune rejection of the allografted islet cells. The therapy is in preclinical development.
- Sep 2023Series C—
- Feb 2021Series C$40M
- May 2017Grant (prize money)—
- Aug 2016Series B—
#8
Funding Raised · Baltimore, Maryland · founded 1980 · 25 employees$344.5Kraised▾
Acousto-optic devices, spectrometers, and hyperspectral imagers innovator and manufacturer, specializing in custom-built solutions. The company designs and manufactures acousto-optic components, AOTF near-infrared spectrometers, and AOTF hyperspectral imagers. They offer free space and fiber-coupled acousto-optic devices, modulators, frequency shifters, Q-switches, deflectors, and tunable filters. Their spectrometers cater to in-line, at-line, and multi-purpose applications. Hyperspectral imagers are available in SWIR or visible spectrums, with options for built-in PCs, telescopes, or microscopes. They serve diverse industries, including pharmaceuticals, food manufacturing, chemical, polymer, and petrochemical. The company focuses on research and development, creating innovative approaches to develop new products and improve existing operations. They provide customer support, product resources, and worldwide distribution. This is a B2B tech company.
- Jan 2025Grant (prize money)$344.5K
#9
Series C · Frederick, Maryland · founded 2003 · 12 employees$39.7Mraised▾
Molecular diagnostics and sample prep solutions for high-quality nucleic acid purification. The company develops, manufactures, and markets integrated molecular diagnostic systems. They offer solutions for nucleic acid extraction from a wide range of samples, delivering high purity and sensitivity. Their product line includes tips and kits designed to optimize sample prep workflows. They focus on providing cutting-edge solutions for academic and clinical research, enabling breakthroughs in nucleic acid extractions. The company's technology offers higher purity than magnetic beads and greater sensitivity than spin columns. They provide products and services related to molecular diagnostics, sample preparation, DNA extraction, RNA extraction, and nucleic acid purification.
- Sep 2021Grant (prize money)$168.1K
- Apr 2021Grant (prize money)$3.3M
- Jun 2019Series C$1.8M
- Aug 2018Grant (prize money)$3M
#10
Deadpooled · Bethesda, Maryland · founded 2017 · 9 employees$35Mraised▾
Developer of therapies for the treatment of cancer. The company uses EDIFY platform to develop cell therapies for cancer patients. The product pipeline includes MANA-312 an allogeneic donor-derived cell therapy for the treatment of acute myeloid leukemia, MANA-412 for solid tumors, and MANA-512 for multiple cancers.
- Nov 2021Venture Debt$7.5M
- Nov 2021Series A—
- Jan 2021Series A$35M
#11
Series D · Rockville, Maryland · founded 1996 · 141 employees$69.6Mraised▾
OriGene Technologies is focused on developing proteins, antibodies, and other molecular tools to support the academic, pharmaceutical, and biotech companies in their research of gene functions and drug discovery. Its product lines include the large cDNA and shRNA clone collections, about 5k purified human proteins, monoclonal antibodies (TrueMAB), 140k validated human tissues, and protein microarray products. It also provides a range of antibody validation products including genome-wide tagged antigen standards and extensive IHC slides derived from the Company's tissue collection.
- Jun 2015Series D$17.1M
- Mar 2014Series C$200K
- Mar 2013Series C$21.3M
- Sep 2012Series B$15M
#12
Seed · Gaithersburg, Maryland · founded 2009 · 13 employees$4.6Mraised▾
HeMemics Biotechnologies specializes in the field of biopreservation. The company's products are based on its patented HeMeDri technology platform for preserving and storing of mammalian cells and perishable biologics. The company's patented preservation solutions, HemSol, are designed to preserve mammalian cells and biologics in desiccated and non-desiccated formats in cold or ambient temperature. The company also provide customized solutions to clients that need to stabilize their products in dried/non-dried, instead of frozen format, for ease of storage and transportation. It can be used to preserve and dehydrate/rehydrate perishable biologics (proteins, cells, and tissues.).
- May 2023Seed$2M
- Dec 2020Seed$100K
- Dec 2019Seed$2.5M
- Apr 2018Seed—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Platforms and Tools coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Bioinformatics in Maryland is moving
A read on the academic research around Bioinformatics in Maryland — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 136 papers.
University of Maryland institutions lead Maryland's bioinformatics research, focusing dominantly on genomics and gut microbiota, with a cautiously optimistic tone reflecting mostly breakthroughs amid some concerns.
- University of Maryland, Baltimore74
- University of Maryland, College Park50
- University of Maryland, Baltimore County9
- Virginia–Maryland College of Veterinary Medicine4
- University of Maryland Extension2
- Genome3→9
- Gene2→5
- Transcriptome3
- Genome3
- Disease3
- Encoding (memory)2
- Antibody2
- Disease5
- Gene3
- Gene duplication2
- Estrogen2
- Gene expression2
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.